PMID: 11913914Mar 27, 2002Paper

Applying evidence-based guidelines improves use of colonoscopy resources in patients with a moderate risk of colorectal neoplasia

The Medical Journal of Australia
Peter A BamptonGraeme P Young

Abstract

To determine whether applying National Health and Medical Research Council (NHMRC) guidelines for colorectal cancer prevention would reduce the number of follow-up colonoscopies. A prospective audit of colonoscopic surveillance decisions before and after the intervention. The endoscopy suite at a metropolitan tertiary hospital three months before and after January 2000. Dissemination of NHMRC guidelines, and supervision of application of the guidelines by a nurse coordinator. We compared colonoscopic surveillance decisions before and after the intervention in two groups of 100 consecutive patients after polypectomy and in two groups of 50 consecutive patients with a family history of colorectal cancer after a normal colonoscopy. Change in concordance of decisions with NHMRC guidelines; and effect on number of follow-up colonoscopies. After the intervention, the proportion of postpolypectomy surveillance decisions matching the guidelines increased from 37% to 96% (P < 0.05). The mean time to repeat colonoscopy after polypectomy increased from 2.7 to 3.5 years (P < 0.005) (ie, a 23% reduction in the number of postpolypectomy surveillance colonoscopies performed per year). Likewise, the proportion of family-history surveillance de...Continue Reading

References

Mar 5, 1992·The New England Journal of Medicine·W S AtkinJ Cuzick
Jan 21, 1991·International Journal of Cancer. Journal International Du Cancer·J O SøndergaardE Lynge
Dec 22, 1994·The New England Journal of Medicine·C S FuchsW C Willett
May 15, 1993·Annals of Internal Medicine·D J St JohnE S Hughes
Jun 1, 1993·Gastroenterology·D J St JohnJ C Penfold
May 13, 1998·The Medical Journal of Australia·J K OlynykJ A Dickinson
Mar 10, 1999·Journal of the National Cancer Institute·J S MandelJ H Bond
Oct 7, 2000·Journal of Gastroenterology and Hepatology·D J DowlingJ L Hopper

❮ Previous
Next ❯

Citations

Mar 27, 2002·The Medical Journal of Australia·Terry BolinMelvyn G Korman
Feb 14, 2008·Cancer Causes & Control : CCC·Anna R GagliardiDave Davis
Oct 7, 2010·International Journal of Evidence-based Healthcare·Jennifer MedvesPaola Durando
Jan 24, 2019·European Journal of Gastroenterology & Hepatology·Erin L SymondsPeter Bampton
Nov 3, 2005·Nature Clinical Practice. Oncology·Douglas B Nelson
Apr 4, 2017·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Erin L SymondsGraeme P Young
Jan 15, 2015·Gut·Else-Mariëtte B van HeijningenMarjolein van Ballegooijen
Nov 4, 2020·Journal of Gastroenterology and Hepatology·Shahzaib AnwarErin L Symonds
Jun 17, 2010·The American Journal of Gastroenterology·David G Hewett, Douglas K Rex
Jan 11, 2019·Digestive Diseases and Sciences·Erin SymondsCharles Cock
Mar 18, 2008·Journal of Clinical Gastroenterology·Sanna A MulderErnst J Kuipers
Oct 3, 2007·Nature Clinical Practice. Gastroenterology & Hepatology·Charles J Kahi, Douglas K Rex
Oct 31, 2002·The Medical Journal of Australia·Finlay A Macrae, Geoffrey S Hebbard
Mar 21, 2007·The Medical Journal of Australia·Charlie H ViialaJohn K Olynyk
May 30, 2009·Cancer·Rob Sanson-FisherDonna Turner
Jan 15, 2015·Internal Medicine Journal·B A Leggett, D G Hewett
Jan 30, 2004·The Medical Journal of Australia·Gautam Ramnath, Peter Bampton
Jun 15, 2018·The Medical Journal of Australia·Bilel Jideh, Michael J Bourke
Mar 21, 2007·The Medical Journal of Australia·Finlay A Macrae

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.